West Pharmaceutical Servi...

NYSE: WST · Real-Time Price · USD
247.84
1.64 (0.67%)
At close: Aug 15, 2025, 9:59 AM

West Pharmaceutical Services Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
484.6M 853.9M 894.3M 762.6M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
202.1M 210M 204.9M 207.7M
Other Long-Term Assets
74.3M 21.3M 38.4M 55.9M
Receivables
552.5M 512M 507.4M 489M
Inventory
377M 434.7M 414.8M 378.4M
Other Current Assets
124M 135.8M 103M 112M
Total Current Assets
1.54B 1.94B 1.92B 1.74B
Property-Plant & Equipment
1.69B 1.51B 1.26B 1.13B
Goodwill & Intangibles
116.9M 123.6M 125.7M 132.9M
Total Long-Term Assets
2.11B 1.89B 1.7B 1.57B
Total Assets
3.64B 3.83B 3.62B 3.31B
Account Payables
239.3M 242.4M 215.4M 232.2M
Deferred Revenue
49.6M 41.7M 57.3M 48.7M
Short-Term Debt
n/a 134M 2.2M 44.2M
Other Current Liabilities
71.6M 54.2M 54M 45.1M
Total Current Liabilities
550.4M 671.8M 519M 594.1M
Long-Term Debt
202.6M 72.8M 206.7M 208.8M
Other Long-Term Liabilities
105.8M 106.7M 98.9M 107.6M
Total Long-Term Liabilities
410.7M 276.7M 412.9M 384.3M
Total Liabilities
961.1M 948.5M 931.9M 978.4M
Total Debt
302.3M 309M 317.9M 325.3M
Common Stock
18.8M 18.8M 18.8M 18.8M
Retained Earnings
3.96B 3.52B 2.99B 2.46B
Comprehensive Income
-258.1M -143.8M -183M -159.6M
Shareholders Equity
2.68B 2.88B 2.68B 2.34B
Total Investments
202.1M 210M 204.9M 207.7M